[vc_row][vc_column][vc_column_text]

Il progetto è realizzato con il contributo incondizionato di 

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text el_class=”underred”]

VIDEO INTERVISTE CON ESPERTI INTERNAZIONALI SU TREND TOPICS SCIENTIFICI DI AMBITO NEFROLOGICO

[/vc_column_text][/vc_column][/vc_row][vc_row el_class=”fisa”][vc_column][vc_tta_accordion active_section=”” css_animation=”fadeInUp” collapsible_all=”true”][vc_tta_section title=”Introduzione Take Away” tab_id=”t1″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRmN6bGY5LUxHcDgwJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRQ==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”HYPONATREMIA: NEW DIAGNOSTIC AND THERAPEUTIC DEVELOPMENTS” tab_id=”t2″][vc_raw_html]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[/vc_raw_html][/vc_tta_section][vc_tta_section title=”LUPUS NEPHRITIS: CAN WE PRESERVE KIDNEY FUNCTION? CURRENT CHALLENGES AND PRACTICAL CONSIDERATIONS TARGETED B-CELL THERAPIES IN LUPUS NEPHRITIS: WHAT DO WE KNOW SO FAR?” tab_id=”t3″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRkNWRmlCbktfNVVRJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRQ==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”PCSK9: A JOURNEY OF DISCOVERY FROM GENETICS TO CLINICAL TRIALS” tab_id=”t4″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRlMyZnp1S2ZjUXBVJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRQ==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”THE FUTURE OF ANEMIA OF CKD: WHERE ARE WE GOING? WHEN TO TREAT, WHY AND CHALLENGES OF MANAGEMENT” tab_id=”t5″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRjlsQXZndkRYXzk0JTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRQ==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”TIME TO ABANDON THE RESTRICTION OF FRUITS AND VEGETABLES IN PATIENTS WITH CHRONIC KIDNEY DISEASE?” tab_id=”t6″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRnhMeV9jV0ZZRlZFJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRSUyMA==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”Genetic-First Approaches In Eskd Of Unknown Significance” tab_id=”t7″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRndjckVfTzd0VTJjJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRSUyMA==[/vc_raw_html][/vc_tta_section][vc_tta_section title=”PROMS CAN REPLACE TRADITIONAL OUTCOMES IN CLINICAL TRIALS? WHAT IS MORE IMPORTANT HEMOGLOBIN VALUE OR PATIENT’S TIREDNESS?” tab_id=”t8″][vc_raw_html]JTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ3d3cueW91dHViZS5jb20lMkZlbWJlZCUyRnc4YjhJQWNFR1ZvJTIyJTIwdGl0bGUlM0QlMjJZb3VUdWJlJTIwdmlkZW8lMjBwbGF5ZXIlMjIlMjBmcmFtZWJvcmRlciUzRCUyMjAlMjIlMjBhbGxvdyUzRCUyMmFjY2VsZXJvbWV0ZXIlM0IlMjBhdXRvcGxheSUzQiUyMGNsaXBib2FyZC13cml0ZSUzQiUyMGVuY3J5cHRlZC1tZWRpYSUzQiUyMGd5cm9zY29wZSUzQiUyMHBpY3R1cmUtaW4tcGljdHVyZSUyMiUyMGFsbG93ZnVsbHNjcmVlbiUyMHdpZHRoJTNEJTIyNjQwJTIyJTIwaGVpZ2h0JTNEJTIyNDgwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUyMiUzRSUzQyUyRmlmcmFtZSUzRSUyMA==[/vc_raw_html][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] 

TOPIC SPEAKER  DISCUSSANT SIN AFFILIATION
HYPONATREMIA: NEW DIAGNOSTIC AND THERAPEUTIC DEVELOPMENTS MIRJAM CHRIST-CRAIN, SWI
Professor of Endocrinology, Diabetes and Metabolism at the University of Basel and the University Hospital of Basel, Switzerland.
GIUSEPPE REGOLISTI  S.C Clinica e immunologia medica, Azienda Ospedaliero-Universitaria di Parma
LUPUS NEPHRITIS: CAN WE PRESERVE KIDNEY FUNCTION? CURRENT CHALLENGES AND PRACTICAL CONSIDERATIONS TARGETED B-CELL THERAPIES IN LUPUS NEPHRITIS: WHAT DO WE KNOW SO FAR? ENRIQUE MORALES, SPA
Renal Transplantation Unit from Hospital Universitario 12 de Octubre, Madrid, Spain.
DARIO ROCCATELLO  Dipartimento di Scienze Mediche, Università di Torino
PCSK9: A JOURNEY OF DISCOVERY FROM GENETICS TO CLINICAL TRIALS CATHERINE BOILEAU, FRA
Professor, Head of service: Molecular Genetics Department, Bichat Hospital – Claude-Bernard Paris
ROBERTO PONTREMOLI  Dipartimento di medicina interna e specialità mediche, Università degli studi di Genova
THE FUTURE OF ANEMIA OF CKD: WHERE ARE WE GOING? WHEN TO TREAT, WHY AND CHALLENGES OF MANAGEMENT  KIRSTEN JOHANSEN, USA
Division Chief Nephrology, Hennepin Healthcare Minneapolis, Minnesota
LUCIA DEL VECCHIO  Dipartimento di Nefrologia e Dialisi  ASST Lariana Como
FRANCESCO LOCATELLI    Dipartimento Nefrologia, Dialisi e Trapianto Renale all’Ospedale A. Manzoni di Lecco
TIME TO ABANDON THE RESTRICTION OF FRUITS AND VEGETABLES IN PATIENTS WITH CHRONIC KIDNEY DISEASE? JUAN JESUS CARRERO, SWE
Professor in cardio-renal Epidemiology at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
ADAMASCO CUPISTI  Dipartimento di Medicina Clinica e Sperimentale dell’Università degli Studi di Pisa
VINCENZO BELLIZZI U.O.C. Nefrologia e Dialisi, Azienda Ospedaliera Universitaria 

San Giovanni di Dio Ruggi d’Aragona – Salerno

GENETIC-FIRST APPROACHES IN ESKD OF UNKNOWN SIGNIFICANCE LAURENT MESNARD, FRA

Sorbonne Université, UPMC · Renal transplantation and Nephrology

CLAUDIA IZZI Ospedali Civili di Brescia, Medico specialista in patologie genetiche e patologie genetiche renali (ADPKD) 
PROMS CAN REPLACE TRADITIONAL OUTCOMES IN CLINICAL TRIALS? WHAT IS MORE IMPORTANT HEMOGLOBIN VALUE OR PATIENT’S TIREDNESS? GIOVANNI TRIPEPI

Italian National Research Council | CNR · Institute of Clinical Physiology IFC, Biostatistician, MSc, PhD, Reggio Calabria 

ROBERTO MINUTOLO  Università degli Studi della Campania “Luigi Vanvitelli · Dipartimento di Scienze Mediche, Chirurgiche, Neurologiche, Metaboliche e dell’Invecchiamento

MD PhD

[/vc_column_text][/vc_column][/vc_row]